DXS International (AQSE:DXSP) ROE %: -23.49% (As of Apr. 2025)


What is DXS International ROE %?

DXS International AQSE:DXSP ROE % is -23.49% as of Apr. 2025. The stock has 2 warning signs investors should review. Among 625 Healthcare Providers & Services companies, DXS International ranks worse than 83.04% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. DXS International's annualized net income for the quarter that ended in Apr. 2025 was £-0.10 Mil. DXS International's average Total Stockholders Equity over the quarter that ended in Apr. 2025 was £0.40 Mil. Therefore, DXS International's annualized ROE % for the quarter that ended in Apr. 2025 was -23.49%.

The historical rank and industry rank for DXS International's ROE % or its related term are showing as below:

AQSE:DXSP' s ROE % Range Over the Past 10 Years
Min: -188.17   Med: 6.4   Max: 14.56
Current: -23.49

During the past 11 years, DXS International's highest ROE % was 14.56%. The lowest was -188.17%. And the median was 6.40%.

AQSE:DXSP's ROE % is ranked worse than
83.04% of 625 companies
in the Healthcare Providers & Services industry
Industry Median: 5.84 vs AQSE:DXSP: -23.49

DXS International  (AQSE:DXSP) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Apr. 2025 )
=Net Income/Total Stockholders Equity
=-0.095/0.4045
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.095 / 3.47)*(3.47 / 2.516)*(2.516 / 0.4045)
=Net Margin %*Asset Turnover*Equity Multiplier
=-2.74 %*1.3792*6.22
=ROA %*Equity Multiplier
=-3.78 %*6.22
=-23.49 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Apr. 2025 )
=Net Income/Total Stockholders Equity
=-0.095/0.4045
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.095 / -0.175) * (-0.175 / -0.129) * (-0.129 / 3.47) * (3.47 / 2.516) * (2.516 / 0.4045)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.5429 * 1.3566 * -3.72 % * 1.3792 * 6.22
=-23.49 %

Note: The net income data used here is one times the annual (Apr. 2025) net income data. The Revenue data used here is one times the annual (Apr. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


DXS International ROE % Related Terms


DXS International ROE % Historical Data

* Premium members only.

The historical data trend for DXS International's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International ROE % Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.75 5.22 5.03 -188.17 -23.49

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 12.75 5.22 5.03 -188.17 -23.49

AQSE:DXSP vs VEEV, BTSG, TEM: ROE % Comparison

For the Health Information Services subindustry, DXS International's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DXS International ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DXS International's ROE % distribution charts can be found below:

* The bar in red indicates where DXS International's ROE % falls into.



DXS International ROE % Calculation

DXS International's annualized ROE % for the fiscal year that ended in Apr. 2025 is calculated as

ROE %=Net Income (A: Apr. 2025 )/( (Total Stockholders Equity (A: Apr. 2024 )+Total Stockholders Equity (A: Apr. 2025 ))/ count )
=-0.095/( (0.447+0.362)/ 2 )
=-0.095/0.4045
=-23.49 %

DXS International's annualized ROE % for the quarter that ended in Apr. 2025 is calculated as

ROE %=Net Income (Q: Apr. 2025 )/( (Total Stockholders Equity (Q: Apr. 2024 )+Total Stockholders Equity (Q: Apr. 2025 ))/ count )
=-0.095/( (0.447+0.362)/ 2 )
=-0.095/0.4045
=-23.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Apr. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -23.49% mean?
DXS International (AQSE:DXSP) has a ROE % of -23.49% as of Apr. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on DXS International and its competitors. According to the industry distribution chart, DXS International ranks #519 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 83%.
Is DXS International's ROE % too high?
DXS International's current ROE % is -23.49%. Based on the distribution chart, DXS International ranks #519 out of 625 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does DXS International's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #519 out of 625 companies for ROE %. This places DXS International in the lower half of its industry. The industry median ROE % is 5.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current ROE % is -23.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 37.5% below its estimated fair value. The current ROE % is -23.49%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current ROE % is -23.49% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DXS International Business Description

Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.